Income Statement

v3.20.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Nov. 30, 2019
Nov. 30, 2018
Nov. 30, 2017
Revenues      
Licensing (Note 3) $ 1,114,031 $ 1,370,607 $ 5,025,350
Up-front fees (Note 3) 2,366,485 342,124 479,102
Revenues 3,480,516 1,712,731 5,504,452
Cost of good sold      
Cost of goods sold 33,068 124,870 704,006
Gross Margin 3,447,448 1,587,861 4,800,446
Expenses      
Research and development 6,608,794 10,827,293 9,271,353
Selling, general and administrative 4,167,801 3,476,450 3,287,914
Depreciation (Note 5) 505,803 610,384 506,961
Expenses 11,282,398 14,914,127 13,066,228
Loss from operations (7,834,950) (13,326,266) (8,265,782)
Net foreign exchange (loss) gain (25,498) 8,592 (80,093)
Interest income 13,535 227 15,037
Interest expense (247,516) (255,231) (389,239)
Financing cost (Note 10) 0 (174,802) (137,363)
Gain on settlement of convertible debt (Note 7) 4,419 0 0
Net loss before income taxes (8,090,010) (13,747,480) (8,857,440)
Provision for income taxes (Note 15)      
Current tax expense 5,678 0 0
Deferred tax recovery (11,042) 0 0
Net loss and comprehensive loss $ (8,084,646) $ (13,747,480) $ (8,857,440)
Loss per common share, basic and diluted $ (0.37) $ (2.89) $ (2.86)
Weighted average number of common shares outstanding, basic and diluted 21,580,059 4,762,274 3,101,448

Source